What is Amulet?
Founded in 2016 and headquartered in Madison, Wisconsin, Amulet is dedicated to illuminating unseen dangers in the food supply chain. The company operates through two primary divisions: Allergy Amulet, which offers a wearable device designed to alert individuals to allergens in their food, and Amulet Scientific, providing food manufacturers with advanced technology for the targeted detection of toxins and contaminants. This dual focus positions Amulet as a comprehensive solution provider in the critical field of food safety.
How much funding has Amulet raised?
Amulet has raised a total of $6.8M across 2 funding rounds:
Series A
$6M
Debt
$758K
Series A (2024): $6M with participation from HealthX Ventures, Incite Ventures, and Great Oaks Venture Capital
Debt (2026): $758K, investors not publicly disclosed
Key Investors in Amulet
HealthX Ventures
HealthX Ventures is a venture capital firm that invests in innovative companies focused on digital health solutions aimed at making healthcare more accessible, efficient, and affordable. Based in Madison, WI, the firm is led by experienced entrepreneurs and investors who provide operational support and industry knowledge to their portfolio companies. They target entrepreneurs raising capital for digital health initiatives and leverage a strong network of providers, payers, employers, and life science dealmakers. HealthX Ventures is dedicated to backing entrepreneurs who create value through scalable healthcare solutions.
Incite Ventures
Incite Ventures is a investment fund firm. It supports mission-driven enterprises through investments. The company is based in Burlingame, california.
Great Oaks Venture Capital
Great Oaks Venture Capital operates as an early-stage investment firm focused on identifying and supporting founders building transformative companies. The firm deploys capital across Pre-Seed, Seed, and Series A funding rounds, working closely with entrepreneurs who are solving meaningful problems across multiple sectors. This hands-on approach to early-stage investing reflects a deep commitment to understanding market dynamics and founder potential at critical inflection points. While maintaining a generalist investment philosophy, Great Oaks has developed particular expertise in software, healthcare, financial services, marketplaces, and enterprise solutions. This sector focus allows the firm to leverage specialized knowledge when evaluating opportunities and supporting portfolio companies through their formative growth phases. The firm's investment thesis emphasizes backing founders with ambitious visions and the capability to execute at scale. Great Oaks has cultivated a portfolio of companies that demonstrate sustained growth and market relevance, reflecting the firm's ability to identify promising ventures early and provide meaningful support beyond capital deployment. The firm's track record illustrates a consistent ability to recognize founders and business models with lasting potential.
What's next for Amulet?
With this substantial enterprise-level backing, Amulet is poised for accelerated expansion and technological advancement. The recent strategic investment, likely a Series A round given the context, suggests a transition from development to scaling operations. Future endeavors will likely involve enhancing their detection technologies, broadening market penetration for both consumer-facing and industrial solutions, and potentially forging new strategic partnerships within the food industry and regulatory bodies. The company's trajectory indicates a strong commitment to leveraging capital for innovation and market leadership in food safety.
See full Amulet company page
